Thread: New drug may limit disease progression, provide better symptom relief to Parkinson's
View Single Post
Old 08-04-2017, 07:20 AM
jeffreyn jeffreyn is offline
Member
  
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
Default
Research paper:
D-512, a novel dopamine D2 / D3 receptor agonist, demonstrates superior anti-parkinsonian efficacy over ropinirole in parkinsonian rats, Lindenbach et al., Br J Pharmacol July 1 2017.
D-512, a novel dopamine D2 / D3 receptor agonist, demonstrates superior anti-parkinsonian efficacy over ropinirole in parkinsonian rats - Lindenbach - 217 - British Journal of Pharmacology - Wiley Online Library
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
eds195 (08-04-2017)